Smoking habits and random measurements of the proportion of haemoglobin bound to carbon monoxide (COHb%) were examined for their association with atherosclerotic diseases in 1068 men aged 55 to 74 years from rural areas of Finland. COHb% and smoking history were similarly associated with claudication and coronary heart disease. Random measurements of COHb% did not show a better overall relation to the prevalence of atherosclerotic diseases than smoking history, though COHb% showed a stronger association with a probable previous myocardial infarction. Further studies are needed to clarify the role of carbon monoxide in atherosclerosis.
Introduction
Cigarette smoking is a known risk factor for atherosclerotic disease. Exposure to cigarette smoke has generally been estimated by interview techniques, the information being based on the amount of tobacco smoked daily. The risk of atherosclerosis, however, is probably related more to the amount of smoke inhaled than to the number of cigarettes smoked, but it is difficult to evaluate the depth of inhalation with interview methods. ' Carbon monoxide constitutes about 40o0 of tobacco smoke and binds with haemoglobin to form a stable compound. Thus the proportion of haemoglobin bound to carbon monoxide (COHb0) should be a good indicator of the depth of inhalation.
We decided to evaluate random estimations of COHb0O in a study of the prevalence of atherosclerotic disease. We also looked for a possible independent association between COHb and atherosclerotic disease.
Subjects and methods
In 1959, 1711 men aged 40-59 years from rural areas of eastern and south-west Finland were enrolled in a cohort study of coronary heart disease (CHD) and other atherosclerotic diseases.2 In 1974 In , 1178 estimated with a special spectrophotometer (182 CO-Oximeter, Instrumentation Laboratory Inc). Methods used to obtain clinical and other data as well as data on smoking habits and serum cholesterol concentrations have been described elsewhere.2 3 All clinical data were evaluated centrally and classified according to set rules.
Subjects were classified as having "definite" CHD when, in the absence of other heart disease (rheumatic, pulmonary, etc), there was a history of angina on effort or of a typical chest-pain attack of at least half an hour's duration4 or when a resting electrocardiogram (ECG) showed Minnesota code5 changes of infarction (code I, 1-3); ischaemic ST waves (IV, 1-3); negative T waves (V, 1, 2); abnormal atrioventricular or ventricular conduction (VI, 1, 2, 4; VII, 1, 2, 4); or atrial fibrillation. Two separate criteria were used to form subgroups of men with myocardial infarction-namely, a history of typical chest-pain attack (with or without ECG abnormalities at survey) and Minnesota code ECG changes I, 1, or I, 2 and V, 1, 2. A standard questionnaire was used4 to diagnose intermittent claudication, and the usual clinical criteria were used to diagnose stroke. Men with other types of heart disease; those with less definite symptoms or signs of CHD, claudication, or cerebrovascular disease; and those on whom data were incomplete were grouped separately. In the analyses of each disease manifestation in relation to smoking and COHb the unaffected men only served as controls.
The subjects were primarily divided into eight subgroups (two areas, four five-year age groups in each). The following categories were used for history of smoking: never smoked, stopped smoking, current smokers (1-9, 10-19, or 20 or more cigarettes a day), and pipe or cigar smokers (no cigarettes).
Partial correlation analysis was used to study the possibility that COHb % was independently associated with atherosclerotic disease.
We chose this statistical procedure to avoid spurious results due to the strong association of the explanatory variables, cigarette consumption and COHb0%. Categories were used for both cigarette consumption (as above) and COHb% (<0-5%4; 0&6-200%; -211%). Thus the correlation coefficients indicate rank correlations between variables.
Results
Altogether 219 (42%) of the men from east Finland (EF) and 164 (30 %) from west Finland (WF) were current smokers. The mean COHb concentration was 190% in east Finnish subjects and 1 7% in those from west Finland. The prevalence of definite atherosclerotic disease was higher in EF than in WF-claudication: EF 10 %, WF 60%; stroke: EF 50%, WF 30%; CHD: EF 390%, WF 280%. The eight age-and area-specific subgroups and the total groups showed similarities in the association of atherosclerotic disease with smoking and COHb %; the results presented here are for the total groups only.
COHb % was strongly related to smoking. There were few differences between those who had never smoked and those who had stopped smoking in their distribution according to COHb % (table I) . COHb concentrations above 2 % were much more common in current smokers than in the other men. The prevalence of claudication was greater among current and former smokers than in those who had never smoked (table II) . COHb concentrations above 20% were associated with an increased prevalence of claudication (table III) . On partial correlation analysis the correlation between COHb % and claudication was low (r=0 16; P<0001). When the effect of cigarette smoking was eliminated the coefficient was reduced by half (r = 0-08; NS). The prevalence of stroke was inversely associated both with cigarette smoking and with COHb% (tables II and III). Nevertheless, only 38 of the men had a history of stroke, and the associations were not significant.
There was a weakly positive association between the prevalence of definite CHD and cigarette smoking, and between CHD and COHb0%; the association was significant (P < 005), however, only for COHb % (tables II and III). On partial correlation analysis COHb % was not correlated with CHD when the influence of cigarette smoking on the correlation coefficient was eliminated. Similarly the occurrence of angina pectoris was weakly associated with both smoking and COHb 0; the associations tended to be significant for both (tables II and III). Smoking was not associated with a history of an attack of chest pain or with ECG signs of myocardial infarction (table  II) . Nevertheless, attacks of chest pain occurred at least twice as often in men with COHb concentrations above 0 5 % compared with those with COHb concentrations of 0 5 % or less (table III) . The correlation between the COHb % and the occurrence of attacks was low (r = 0 13; P <0001). The correlation coefficient remained unchanged (r=0 13) on partial correlation analysis after eliminating the influence of smoking.
When studied separately in the three groups according to cigarettesmoking habit, the association of chest-pain attacks with raised COHb % was particularly clear in the ex-smokers (table IV) 6 (1 3) 9 (1-9)
No (') made at random, which gives a good indication of the mean COHb concentration in smokers.7 A history of an attack of chest pain suggesting myocardial infarction was associated with raised COHb concentrations; a similar relation was not found for smoking history. The association was unlikely to have been caused by greater frequency of "false" attacks of chest pain in men with raised COHb concentrations because. a similar association was found for ECG signs of myocardial infarction. The association was mainly caused by slight rises in COHb concentration (06-2O0O0). The finding of this association among ex-smokers was unexpected; occasional smokers who had already had a myocardial infarction may have denied their habit more often than the other men.
Because our subjects were middle-aged and older men from rural areas, we cannot make generalised conclusions. Furthermore, a cross-sectional study such as this has sources of bias: for instance, the men who had diseases associated with smoking may have altered their smoking habits. A prospective population study is needed to clarify the role of carbon monoxide in atherosclerosis.
Introduction
Should women who have had induced abortions be afraid of additional risk in subsequent, wanted pregnancies ? Englishl-3 and eastern European4-7 studies show increased numbers of second-trimester spontaneous abortions and premature deliveries in women becoming pregnant after induced abortions. We aimed to evaluate the risks of such complications in Dutch women. 
Patients and methods
The analysis was carried out in the department of obstetrics, Wilhelmina Gasthuis, University of Amsterdam. From January 1972 to June 1976 we reviewed 3780 primiparae admitted to this department who delivered at 17 weeks' gestation or more. Of these women, 265 (70 0%) had had at least one previous induced abortion (group A). The second group consisted of 348 primiparae (9 2 %) who had had at least one spontaneous abortion and no induced abortions (group B). A third group of 3167 women (83 8 '/) had had no abortions (group E).
Age-matched controls were selected for each woman in groups A and B from primiparae delivering immediately afterwards who had no history of abortion (groups C and D). We compared gestational age at delivery between these four groups and between groups A, B, and E. When the date of the last menstrual period was not exactly known, gestational age was estimated from information on prenatal care, birth weight, and Dubowitz score.
In addition to the material from our own department, we had at our disposal data kindly supplied by GVR (Gemeenschappelijke Verloskundige Registratie-that is, Co-operative Obstetric Registration). In this register, data are collected from 11 obstetric departments in various regions of the Netherlands."' By adding these data to our own, we could study material from 12 departments. From this we selected only primiparae for whom gestational age of pregnancy was known. We excluded women with multiple pregnancies and those who had undergone conisation of the cervix or had uterine scars or congenital malformations of the uterus.
Thus our total series included 14 495 primiparae, of whom 12 678 had no history of abortion (87 50o), 504 had had a previous induced abortion (3 4%), and 1313 a spontaneous abortion (9 1 %). We compared gestational age at delivery in these larger groups.
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